Join Examsbook
766 1

Q:

Which institute received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir?

  • 1
    Employees' state Insurance Corporation
  • 2
    CSIR-Central Drug Research Institute
  • 3
    The Indian Council of Medical Research
  • 4
    All India Institute Of Medical Science
  • Show AnswerHide Answer
  • Workspace

Answer : 2. "CSIR-Central Drug Research Institute"

Previous Next

Current GK Current GK Questions

Are you sure

  Report Error

Please Enter Message
Error Reported Successfully